ZKIN - Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
Lantheus Holdings shares dipped 22.5% to $58.93 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Invivyd, Inc. (NASDAQ: IVVD) shares surged 170% to $4.40 after the company reported positive initial results from ongoing CANOPY Phase 3 pivotal clinical trial investigating VYD222 for the Prevention of COVID-19.
- Cuentas Inc. (NASDAQ: CUEN) shares climbed 71.6% to $2.37.
- iCoreConnect Inc. (NASDAQ: ICCT) shares jumped 49.4% to $2.54 after surging over 73% on Friday.
- ZimVie Inc. (NASDAQ: ZIMV) gained 42.8% to $16.03 after the company disclosed an agreement to sell its spine business to H.I.G. Capital for $375 million.
- Biomerica, Inc. (NASDAQ: BMRA) climbed 42.4% to $1.41. Biomerica received FDA 510(k) clearance for its Hp Detect Stool Antigen ELISA test, designed to detect the presence of the H. pylori bacteria.
- Akso Health Group (NASDAQ: AHG) gained 41.6% to $0.8499.
- Energy Services of America Corporation (NASDAQ: ESOA) surged 35.4% to $4.7399 following FY23 earnings results.
- LQR House Inc. (NASDAQ: LQR) gained 30.9% to $3.3649.
- United States Steel Corporation (NYSE: X) rose 26.5% to $49.77 after Nippon Steel announced it will acquire the company for $55 per share in an all-cash transaction.
- Color Star Technology Co., Ltd. (NASDAQ: ADD) climbed 26.5% to $0.50.
- ZK International Group Co., Ltd. (NASDAQ: ZKIN) rose 22.3% to $1.26.
- Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) shares gained 22.2% to $0.2750 after dipping around 24% on Friday.
- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) gained 21.3% to $2.96 after the FDA approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older.
- Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) climbed 20.5% to $0.6143. Noble Capital Markets ...